RC
Ra Capital Management, L.P. cut its LENZ stake below 5%
Ra Capital Management, L.P. reported owning 0.2% of LENZ Therapeutics, Inc. (LENZ) (70,533 shares) in a Schedule 13D filed Nov 2, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 2, 2026
- Source
- Schedule 13D